 |
|
Hyperammonemic encephalopathy: An unusual presentation of fibrolamellar hepatocellular carcinoma
Nimish Thakral, Douglas A. Simonetto
Clin Mol Hepatol. 2020;26(1):74-77. Published online 2019 Aug 16 DOI: https://doi.org/10.3350/cmh.2018.0042
|
|
Citations to this article as recorded by
 A Case of Non-cirrhotic Hyperammonemic Encephalopathy in a Patient With Metastatic Gastrointestinal Stromal Tumor
Il Seok D Jeong, Parinaz Abiri, Johnny Cai, Catherine Yim, Leland Powell
Cureus.2023;[Epub] CrossRef Disruption of proteome by an oncogenic fusion kinase alters metabolism in fibrolamellar hepatocellular carcinoma
Solomon N. Levin, Michael D. Tomasini, James Knox, Mahsa Shirani, Bassem Shebl, David Requena, Jackson Clark, Søren Heissel, Hanan Alwaseem, Rodrigo Surjan, Ron Lahasky, Henrik Molina, Michael S. Torbenson, Barbara Lyons, Rachael D. Migler, Philip Coffino
Science Advances.2023;[Epub] CrossRef Update on the Pathology of Pediatric Liver Tumors: A Pictorial Review
Priyanka Bhagat, Mukul Vij, Lexmi Priya Raju, Gowripriya Gowrishankar, Jagadeesh Menon, Naresh Shanmugam, Ilankumaran Kaliamoorthy, Ashwin Rammohan, Mohamed Rela
Diagnostics.2023; 13(23): 3524. CrossRef WITHDRAWN: Refractory Hyperammonemic encephalopathy in Fibrolamellar hepatocellular carcinoma, a case report and literature review
Arwa Ahmed, Fateen Ata, Mohammed Gaber, Mahir Petkar, Ahmed Mahfouz, Peter Schirmacher, Sara Musa, Ahmed Hashim
Current Problems in Cancer: Case Reports.2022; : 100141. CrossRef Refractory Hyperammonemic encephalopathy in Fibrolamellar hepatocellular carcinoma, a case report and literature review
Arwa Ahmed, Fateen Ata, Mohammed Gaber, Mahir Petkar, Ahmed Mahfouz, Peter Schirmacher, Sara Musa, Ahmed Hashim
Current Problems in Cancer.2022; 46(3): 100847. CrossRef Epidemiological and Clinical Characteristics of Five Rare Pathological Subtypes of Hepatocellular Carcinoma
Xiaoyuan Chen, Yiwei Lu, Xiaoli Shi, Guoyong Han, Long Zhang, Chuangye Ni, Jie Zhao, Yun Gao, Xuehao Wang
Frontiers in Oncology.2022;[Epub] CrossRef Pediatric Primary Hepatic Tumors: Diagnostic Considerations
Bryony Lucas, Sanjita Ravishankar, Irina Pateva
Diagnostics.2021; 11(2): 333. CrossRef Dexamethasone/nivolumab/prednisone
Reactions Weekly.2020; 1798(1): 107. CrossRef Fibrolamellar hepatocellular carcinoma-related hyperammonemic encephalopathy: Up to now and next steps
Rodrigo Cañada Trofo Surjan, Elizabeth Santana dos Santos, Sergio do Prado Silveira, Fabio Ferrari Makdissi, Marcel Autran Cesar Machado
Clinical and Molecular Hepatology.2020; 26(2): 231. CrossRef Clinical features and surgical outcomes of fibrolamellar hepatocellular carcinoma: retrospective analysis of a single-center experience
Anastasia Lemekhova, Daniel Hornuss, Georgios Polychronidis, Philipp Mayer, Christian Rupp, Thomas Longerich, Karl-Heinz Weiss, Markus Büchler, Arianeb Mehrabi, Katrin Hoffmann
World Journal of Surgical Oncology.2020;[Epub] CrossRef
|